afaq news
The European Medicines Agency (EMA) said on Tuesday that it remains “firmly convinced” that the benefits of the AstraZeneca COVID-19 vaccine outweigh the risks of side effects after a dozen European countries suspended the use of the jab.
Emer Cooke, executive director of EMA, said experts were currently carrying out a “very rigorous analysis” and will deliver their conclusions on Thursday, the “euoronews” reported on Tuesday.
Cooke reiterated however that the number of thromboembolic events reported in vaccinated people “seems not to be higher than that seen in the general population” and that the watchdog remains “firmly convinced that the benefits of the AstraZeneca vaccine in preventing COVID-19, with its associated risk of hospitalisation and death, outweigh the risks of side effects.”
Several European countries suspended the AstraZeneca vaccine after the reports of blood clots. Globally, the vaccine’s distribution remained undisturbed, according to the World Health Organization (WHO), which maintains that the vaccine is safe and effective.
عذراً التعليقات مغلقة